EPHX2 and colorectal carcinoma: We found the clinical correlation between EPHX2 and CRC for the first time, confirmed its role in inhibiting the invasion and promoting apoptosis of CRC cells, and predicted that it may promote fatty acid degradation and inhibit the progression of CRC through peroxisomes.